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Abstract
Background: NEK1, the first mammalian ortholog of the fungal protein kinase never-in-mitosis A (NIMA), is
involved early in the DNA damage sensing/repair pathway. A defect in DNA repair in NEK1-deficient cells is
suggested by persistence of DNA double strand breaks after low dose ionizing radiation (IR). NEK1-deficient cells
also fail to activate the checkpoint kinases CHK1 and CHK2, and fail to arrest properly at G1/S or G2/M-phase
checkpoints after DNA damage.
Results: We show here that NEK1-deficient cells suffer major errors in mitotic chromosome segregation and
cytokinesis, and become aneuploid. These NEK1-deficient cells transform, acquire the ability to grow in anchorage-
independent conditions, and form tumors when injected into syngeneic mice. Genomic instability is also manifest
in NEK1 +/- mice, which late in life develop lymphomas with a much higher incidence than wild type littermates.
Conclusion: NEK1 is required for the maintenance of genome stability by acting at multiple junctures, including
control of chromosome stability.
Background
Cancers frequently develop abnormal numbers of chro-
mosomes and contain chromosomal rearrangements.
This genomic instability generates daughter cells that
die because of insufficient complements of chromo-
somes, as well as polyploid cells that acquire mutations
favorable for uncontrolled proliferation. Genomic
instability is less frequently observed in non-cancerous
cells, which have competent surveillance mechanisms to
monitor errors in DNA replication and chromosome
segregation during mitosis, as well as the machinery to
repair such damage. Dysregulation of these two impor-
tant mechanisms leads to genomic instability, and ulti-
mately to increased mutation rates and acquisition of
the multiple mutations that lead to cancer.
Mitotic protein kinases, such as never-in-mitosis A
(NIMA) in fungi and NIMA-related kinases (Neks or
Nrks) [1] in mammals, have been implicated in guarding
the integrity of the genome. NIMA functions as a protein
kinase, regulates G2-M phase progression, increases
expression in response to DNA damage, and serves to
ensure proper mitotic spindle organization and formation
of the nuclear envelope [2-4]. There are 11 known mam-
malian NEKs. NEK2 is the one best characterized to date.
It has been shown to have a role in controlling orderly
mitosis and in preventing chromosomal instability [1,5,6].
NEK6 and NEK7 have been implicated in regulating
mitotic progression [7,8]. Nek8, like NEK1, has been
linked genetically with a form of polycystic kidney dis-
ease; it localizes to the primary cilium of each cell where
it functions to anchor mitotic centrosomes [9-12].
NEK11 has been linked to the CDC25A degradation in
response to DNA damage and is a substrate of CHK1
[13]. Thus, like their lower eukaryotic orthologs, the NEK
family of kinases has many members. Each seems to have
its unique cellular function, a function required for
orderly progression through the cell division cycle.
Recently, we uncovered a role for NEK1 in DNA
damage responses [14,15]. NEK1 is a dual serine-threonine
and tyrosine kinase [16] and its kinase activity and expres-
sion are quickly upregulated in cells treated with IR.
Within minutes after exposure to IR or other genotoxic
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plasm into the nucleus, where it forms discrete nuclear
foci at sites of DNA damage. NEK1 colocalizes with g-
H2AX and MDC1/NFBD1, which are among the first
responders to IR-induced double strand breaks (DSBs).
The importance of NEK1 in the DNA damage signaling
pathway was revealed by analyzing cells lacking func-
tional NEK1. These cells fail to activate downstream
checkpoint proteins, such as CHK1/CHK2, and fail to
arrest at S or G2/M phase to allow for efficient DNA
repair [14,15]. Consequently, NEK1-deficient cells
develop many more chromosome breaks than wild type
cells [14,15].
Because NEK1 mRNA is abundantly expressed in
mouse gonads and neurons [16], early reports suggested
that NEK1 protein functions in a direct and unique way
in meiosis or in regulating the cell division cycle [17,18].
Whether NEK1 plays a role in regulating chromosomal
stability is still unknown at this time. Neither is it
known whether NEK1 functions as a tumor suppressor
like many checkpoint/mitotic kinases (CHK1, Mps1, and
BubR1). In this report, we demonstrate that NEK1 is
important for genomic and chromosome stability. Cells
defective in NEK1 suffer from disordered mitosis,
become aneuploid after multiple cell division cycles, and
acquire transforming activity. NEK1 also seems to func-
tion as a tumor suppressor, since mice heterozygous for
a NEK1/kat2J mutation develop tumors, specifically lym-
phomas, with a much higher incidence compared to
their wild type littermates.
Methods
Cell culture
Primary renal tubular epithelial cells (RTEs) and tail
fibroblasts were obtained from NEK1-mutated kat2J
mice and their wild type littermates as previously
described [15], and cultured in the Ham’s F-12/DMEM.
Antibodies
Anti-a-tubulin mAb DM1A and rabbit anti-mouse CD3
were purchased from Sigma-Aldrich (St. Louis, MO,
USA), rabbit anti-CD45R antibodies from Abcam, Inc.
(Cambridge, MA, USA), rabbit anti-p19ARF antibodies
from Genetex (Irvine, CA, USA), fluorochrome-conju-
gated secondary antibodies (Alexa-Fluoro 488 for green,
Alexa-Fluoro 594 for red) from Molecular Probes, Inc.
(Eugene, OR, USA), and horseradish peroxidase-based
secondary antibodies from Vector Technologies (Burlin-
game, CA, USA).
Immunocytochemistry
Cells grown on coverslips to 60% confluence were fixed
in 4% formaldehyde with 0.1% Triton X-100. Fixed cells
were permeabilized with 0.05% saponin and blocked
with 10% normal goat serum. Primary antibodies were
u s e da tad i l u t i o no f1 : 1 0 0t o1 : 1 , 0 0 0( 3t o0 . 3μg/mL)
in 10% goat serum. Secondary antibodies, including
anti-rabbit or anti-mouse IgG-Alexa 594 (red) and anti-
rabbit or anti-mouse IgG-Alexa 488 (green; Molecular
Probes, Eugene, OR, USA) were used at a dilution of
1:3,000. Cells were mounted in Permafluor (Lipshaw-
Immunon, Pittsburgh, PA, USA). Images were captured
with a Ziess AxioPlan2 fluorescence microscope and
digitally merged where appropriate.
Chromosome spreads
Mouse RTEs in logarithmic growth phase were treated
with colchicine (1 μg/ml, from Sigma) for 30 min at 37°C.
All cells, including those in the supernatants, were then
collected by trypsinization and swollen in 75 mM KCl
for 15 min at 37°C. Disbursed cells were then fixed with
freshly prepared methanol: acetic acid (3:1). Free chro-
mosomes were dropped onto slides and stained with
Giemsa.
Flourescence-activated cell sorting
Monolayers of the same primary RTEs were trypsinized,
washed with Ham’s F12/DMEM containing serum to
inactivate the trypsin, and then washed with PBS. Spleen
and lymohoma tissues were disrupted in PBS using a
rubber policeman. The tissue homogenates were passed
through 70-μm filter to obtain single cell suspensions.
Cells were well suspended in 1 ml of PBS before fixation
with ethanol to a final concentration of 70%. The fixed
cells were washed again with PBS, treated with RNase,
and labeled with propidium iodide (1 μg/ml) before
sorting by a Becton Dickinson instrument.
Soft agar colony formation
Soft agar colony formation assays were performed as
previously described [15]. Equal numbers of cells (1 ×
10
5 or 2 × 10
4) from each of the indicated cell types at
different passage were seeded in 0.367% agar. After 21
days of incubation at 37°C, colonies containing at least
50 cells were counted and representative colonies were
photographed.
In Vivo Tumor Growth
Monolayers of the RTEs at passage 7 were trypsinized and
resuspended in 1 ml of PBS at a density of 2.5 × 10
7/ml.
5×1 0
6 cells were injected subcutaneously into the flanks
of NEK1 +/- kat 2J mice. Tumor formation was observed
at intervals starting at 7 days later and tumors were har-
vested at day 10 or 21 for histological analysis.
NEK1-mutated kat2J mice and genotyping
C57BL/6J-NEK1kat2J +/- founder mice were obtained
from The Jackson Laboratory (Bar Harbor, ME, USA).
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4 cultured
cells, tail fragments tissue, or blood, according to a pro-
tocol available at http://www.jax.org/imr/tail_nonorg.
html. Details of the genotyping for the kat2J mutation,
a single guanine insertion at nucleotide +996 that results
in a truncated, unstable protein missing the entire
kinase domain [9], and the single-strand conformational
polymorphism (SSCP) analysis have already been
described in detail [14,15]. We have since modified the
published protocol only to eliminate the need to use
radioactive isotope in the detection of bands on polya-
crylamide gels. Gels were fixed with 10% methanol/10%
glacial acetic acid, stained with 4× gel red dye, and
visualized and photographed with a UVP image system.
Generation of inducible knockdown and retrovirus
expression constructs
An inducible shRNAi construct to knock down NEK1
expression was designed and made as previously
described [19]. Briefly, Nek1 shRNA expression cassette
was created in pTER (pTER-NEK1i). Four such cassettes
from pTER-NEKi were inserted in tandem into pPUR
(pPUR-4xNEK1i). U2-OS cells with inducible NEK1
shRNA [14] were established by Lipofectamine 2000-
mediated transfection of pPUR-4xNEK1i and a TetR-
expressing construct, pCDNA6TR, followed by selection
with 5.0 μg/ml blasticidin and 5.0 μg/ml puromycin.
N27 was isolated as an inducible NEK1 knockdown
clone initially, but later became a line with constitutive
knockdown. Passage number 1 was defined as the cells
when they were first established to knock down NEK1
expression stably. For the retrovirus expressing wild-
type NEK1, GFP-tagged NEK1 was subcloned into retro-
viral vector pQUXIP, with a modification to replace the
CMV-IE promoter with a UBC promoter. Retrovirus
was produced by co-transfection of pQUXIP-GFP-Nek1
and VSV-G into 293-GP2 cells.
Histology and immunohistochemistry
Different tissues were harvested immediately after mice
were euthanized, and fixed overnight in 10% neutral
buffered formalin at 4°C. After progressive dehydration
and embedding in paraffin, 3-μm sections were stained
with Meyer’s hematoxylin and eosin reagents. For
immunohistochemical staining, 4-μm tissue sections on
slides were deparaffinized with Histoclear (National
Diagnostics, Atlanta, GA, USA) and rehydrated with
graded ethanol. Primary antibodies including anti-CD3
and anti-CD45R were used to stain for markers of T
or B lymphocytes. Biotinylated secondary, anti-mouse
and anti-rabbit IgG antibodies and immuno-peroxi-
dase-based ABC development kits were purchased
from Vector Laboratories (Burlingame, CA, USA).
Immunoperoxidase-stained sections were then counter-
stained with methyl green to identify nuclei.
Results
Chromosome instability in NEK1-deficient cells
Cells with defective spindle checkpoints or defective
DNA repair mechanisms fail to arrest cell cycle progres-
sion in time to allow proper DNA repair. Thus they fail
to allow the damage to be repaired before dividing. Con-
sequently, unrepaired DNA results in micronucleated
cells, which are markers for genomic instability [19,20].
To investigate NEK1’s role in checkpoint activation
further, we performed detailed analysis of cells without
functional NEK1. Primary RTE cells established from
kat2J mice [9], in which both NEK1 alleles are mutated
(NEK1 -/-), and from wild type littermates (NEK1 +/+)
were examined after staining with DAPI to reveal their
nuclear morphology (Figure 1). Evidence of DNA
damage owing to cell cycle checkpoint defects was
observed in the interphase nuclei of many NEK1 -/-
cells. Multiple nuclei, micronuclei, bridging chromo-
somes, and unique hollown u c l e iw e r ep r o m i n e n t
(Figure 1A, panels b-d). Morphologically normal nuclei
were observed in the vast majority of cells from wild
type littermate mice or from similarly aged C57Bl/6J
mice, the strain from which kat2J mice were generated
(Figure 1A, panel a). Cells established from C57Bl/6
mice were used to make sure that observed abnormal-
ities did not stem only from inbreeding in the NEK1/
kat2J strain. NEK1 -/- cell lines, RTEs and tail fibro-
blasts, were established from at least 8 different mice,
and similar abnormalities were observed in each of
them.
NEK1 mutation results in disordered mitosis
The aberrant nuclear morphology observed in inter-
phase NEK1 mutant cells is a hallmark of defective
mitosis. A significant population of NEK1 localizes to
centrosomes, where it is thought to facilitate functions
in centrosome duplication and stability maintenance
[12,21]. We therefore hypothesized that the lack of
NEK1 might impact centrosome function, thereby affect
mitotic spindle formation, and lead to aberrant chromo-
some segregation. To test these possibilities, we exam-
ined the mitotic spindles and chromosomes of wild type
and NEK1 -/- mutant cells. We found that early passage
cells NEK1 -/- cells (passages 3 and 4) often have multi-
polar spindles (Figure 2f) and lagging chromosomes
(Figure 2g, h), which result in improper chromosome
movement (Figure 2i-k) and bizarre, incomplete cytokin-
esis (Figure 2l-n). These aberrant events were rarely
observed in wild type cells. The aberrant mitoses in
NEK1-deficient cells seemed to explain the abnormal
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Page 3 of 13Figure 2 NEK1 mutation results in disordered mitosis. Normal mitotic phases in primary passage 4 RTE cells from wild type littermate are
shown in upper panels (a-e). DNA stained with DAPI fluoresces blue and secondarily recognized a-tubulin immunofluoresces red. In contrast,
NEK1 -/- cells often undergo faulty and disordered mitosis (f-n), characterized by multipolar spindles (panel f), lagging chromosomes (panel g &
h), improper directional movement of chromosomes or chromosome pieces during anaphase and telophase (panels i, j & k), and bizarre,
incomplete types of cytokinesis (panel l, m & n). Grayscale panels are high-contrast images of the same panels above them, demonstrating
individual staining for either a-tubulin or DAPI.
Figure 1 Genomic instability in NEK1 deficient cells. A. Renal tubular epithelial cells from wild type and NEK1/kat2J -/- mice were fixed with
4% paraformaldehyde during exponential phase growth and stained with DAPI for nuclear morphology Almost all wild type cells had normal
nuclear morphology (panel a). NEK1 -/- cells often had micronuclei (panel b, small arrows), multiple nuclei (panel c, arrows), or hollow nuclei
(panel d, arrow heads). Chromosome bridges were also frequently observed (panel b, large arrow). B. Each histogram represents percentages
(means ± standard errors) of each type of abnormal nuclei from 2 distinct cell lines at passage 4, and totals of 1000 cells scored per cell line.
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phase nuclei (Figure 1).
Aneuploidy in NEK1 -/- cells
We have previously shown that NEK1 -/- cells suffer from
numerous chromosome breaks, and that NEK1 has an
important role in DNA damage checkpoint control [14].
The array of abnormalities we observed in mitotic NEK1
-/- cells, especially the lagging chromosomes and bizarre
incomplete cytokinesis, suggested a potential role for
NEK1 in the spindle checkpoint. To explore the extent
of chromosomal abnormalities further, we analyzed
chromosome spreads. In wild type cells, 40 normal mitotic
chromosomes were observed in >90% of the spreads. In
contrast, only 25% of the mitotic spreads from NEK1 -/-
cells contained 40 chromosomes (Figure 3A, B). While the
vast majority of wild type cells had diploid (2n) chromo-
some copy number, NEK1 -/- cells had variable numbers
of chromosomes (median = 62) (Figure 3B). Hypoploid
spreads were relatively rare, especially in late passage cells,
but a significant fraction (74%) of NEK1 -/- cells had chro-
mosome numbers greater than 4n. These findings suggest
that NEK1 -/- cells fail to undergo cytokinesis properly.
Giemsa staining showed that chromosomes from
Figure 3 Aneuploidy in NEK1 -/- cells. (A, B). Passage 4 RTEs cultured from NEK1 -/- mice and from wild type littermates were treated with
colchicine and hypotonically lysed. Free chromosomes were dispersed and stained with Giemsa. A. Representative images of chromosome
spreads. Note the more variable sister chromatids observed in the spread prepared from NEK1 -/- cells. Bar = 50 μM. B. Numbers of
chromosomes per cell were quantified (more than 200 spreads from at least two unique cell lines for each genotype). (C, D) Wild type or NEK1
-/- RTEs at passage 4 were harvested during exponential phase growth, stained with propidium iodide, and quantified by FACS for DNA content.
C. Plots for wild type cells show sharp 2n and 4n peaks. One NEK1 -/- line (#432) shows a substantial fraction of cells with >4n DNA content
(yellow). In another NEK1 -/- line (#436), the majority of the cells have >2n DNA content, and a broad peak is seen, representing a range of
different DNA content in individual cells. D. Histograms showing 5-13% of cells with >4n DNA content and 6-9% with DNA content intermediate
between 2n and 4n, specifically in NEK1 -/- RTEs.
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somes, and that sister chromatids (Figure 3A, arrows)
were often unequal in length. This latter finding suggests
chromosome rearrangements.
To analyze aneuploidy further in NEK1 -/- cells, fluor-
escence-activated cell sorting (FACS) was used to quan-
tify the DNA content in wild type and NEK1 -/- cells.
To control for any underlying genomic instability asso-
ciated with inbreeding in the parental kat2J mouse
strain, we always used untransformed cells from sex-
matched, wild type littermate mice as controls.
NEK1 -/- cells became polyploid after only a few pas-
sages, whereas wild type cells maintained consistent
DNA content through dozens of population doublings
in culture, until very late passages (Figure 3C, D). Fewer
numbers of cells were observed to be hypoploid, as
expected, since such cells would be unlikely to propa-
gate to future generations [22].
Transforming phenotype in NEK1 -/- cells
To confirm our findings, we used FACS to analyze renal
tubular epithelial cells (Figure 4) and tail fibroblasts (data
not shown) derived originally from littermate mice, but
passed different numbers of times in culture. In all cell
types, only small numbers of wild type cells had DNA con-
tent >4n, especially in early passages. In higher passages,
wild type cells still contained normal 2n and 4n popula-
tions and only small populations of cells had DNA content
>4n (Figure 4A). In contrast, NEK1 -/- cells cultured in
identical conditions and undergoing the same number of
passages (and presumably the same or similar number of
cell divisions), were mostly polyploid after the 4th passage
Figure 4 Polyploid DNA content by FACS and lack of contact inhibition in NEK1 -/- cells. RTEs cultured from NEK1 -/- mice and from wild
type littermates were harvested at different passages during exponential phase growth, stained with propidium iodide, and quantified with
FACS for DNA content. A. Wild type cells show sharp 2n and 4n peaks in early and late passage cells. B. NEK1 -/- cells show 2n and 4n peaks at
early passages. As cells proliferate in culture, 2n population cells disappear and cells with DNA content between 2n and 4n increase in later
generations. NEK1 -/- cells surviving at higher passages have >6n DNA content; few 2n or 4n cells are seen. (C, D.) Growth properties of wild
type and NEK1 -/- cells. Cells at passage 3 or 9 were cultured until they reached 100% confluence, and then cultured for additional of 2 weeks,
until no more proliferation was observed in wild type cells. NEK1 -/- cells continued to pile, beyond monolayers. C. Representative morphology
of the cells immediately before harvest. D. Saturation density of cells was quantified as number of cells per cm
2. Each histogram represents
mean ± standard error from 2 different cell lines in duplicate plates.
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difficult to propagate beyond the 12th passage, but NEK1
-/- cells continued to proliferate easily, suggesting that
NEK1 -/- cells escaped senescence and became sponta-
neously immortalized. NEK1 -/- cells also exhibited other
qualities of cancer cells, including loss of contact inhibi-
tion to allow for multilayered growth, and the ability
to grow at higher saturation density than wild type cells
(Figure 4C, D). Taken together, the many chromosomal
abnormalities observed in NEK1 -/- cells reveal the impor-
tance of NEK1 in DNA damage checkpoints, especially in
control of mitotic checkpoints. Failure to activate DNA
damage checkpoints in NEK1 -/- cells apparently leads to
chromosome instability and aneuploidy, hallmarks of neo-
plastic cell growth.
NEK1 -/- cells grow without anchorage dependence and
form tumors when injected into syngeneic mice
T h ep h e n o t y p e sw eo b s e r v e di nNEK1 -/- cells
prompted us to look for neoplastic behavior. A good
predictor of whether cancer cells can form tumors in
vivo is their ability to grow in soft agar without attach-
ment to plastic. We therefore employed the soft agar
assay to look for anchorage-independent colony forma-
tion in NEK1 -/- and wild type RTEs derived from sex--
matched, littermate mice and cultured in identical
conditions. At different passages, well-separated cells
were seeded into soft agar and examined for their ability
to form colonies. As early as passage five, small numbers
of NEK1 -/- cells were observed to form colonies. At
higher passages, NEK1 -/- cells were even more efficient
in forming colonies. In contrast, wild type cells grew
poorly and failed to proliferate beyond the single cell
stage in the soft agar, even after many passages in
monolayer culture (Figure 5A). NEK1 inactivation there-
fore seems to lead to a transformed phenotype in clones
of cultured cells.
To extend our observation, we injected NEK1 -/- or
wild type RTEs into kat2J mice and analyzed the cells’
ability to form tumors in vivo. Since NEK1 -/- cells at
passage 7 already were polyploid by FACS analysis, and
since they were able to form colonies in soft agar, cells
Figure 5 Cultured NEK1 -/- cells form colonies in soft agar and tumors in when injected into mice. A, B. Equal numbers of unclumped
cells (high density (1 × 10
5/60 mm); low density, (2 × 10
4/60 mm) of the indicated passage were seeded in duplicate in 0.367% agar. Total
colony numbers were scored after 21 days. Contiguous clusters of >50 cells were considered colonies. Representative colonies were
photographed as shown in B. Bar = 100 μm. C. H&E stained sections of tumors, 21 days after subcutaneous injection of NEK1 -/- RTEs into kat2J
mice. Cy = cyst, arrows = abnormal nuclei. Bars = 100 μm. D. p19ARF expression in two distinct NEK1 -/- cell lines at different passages in
culture, and in wild type (NEK1 +/+) cells at passage 7. Alpha tubulin expression served to control for protein loading in each lane.
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NEK1 -/- cells formed visible tumors at injection sites.
Wild type cells did not form any palpable tumors. At
day 10 after injection, the tumors reached maximum
size, and thereafter shrank slightly (mean tumor volume
was 193 μl at day 10 (n = 4) and 137 μl( n=6 )a td a y
21). Tumors were harvested and examined histologically.
Cysts were observed in the tumors grossly and con-
firmed by microscopic examination (Figure 5B). There
was no histological evidence of unusual neo-vasculariza-
tion, nor any major changes in vascularization between
day 10 and day 21 tumors. Many of the cells within the
somewhat pleomorphic tumors had bizarre, ring nuclei
(Figure 5C) reminiscent of the hollow nuclei seen in cul-
tured NEK1 -/- RTEs. The histological features of the
tumors were similar to those observed in colonies
g r o w ni ns o f ta g a r( n o ts h o w n ) .T oh e l pd e t e r m i n e
whether the p16INK/p19ARF pathway, which is com-
monly affected in cancers [23], is downregulated in
tumors mediated by Nek1 deficiency or inactivation, we
examined p19ARF in NEK1 -/- cells. p19ARF expression
was not altered (Figure 5D) in NEK1 -/- cells, even after
multiple passages. This result suggests that NEK1 inacti-
vation leads to tumor formation independent of
p19ARF.
Spontaneous tumors in NEK1 +/- mice
NEK1 deficient cells segregate their chromosomes aber-
rantly and gain a polyploid, transformed phenotype. In
vivo, NEK1 -/- kat2J mice develop polycystic kidney dis-
ease at a young age and often do not survive past 3
weeks after birth (unpublished result). In the few NEK1
-/- kat2J mice that we did observe to survive to two
months of age, 50% (3/6) developed lymphomas and the
other 50% (3/6) had lymphoid aggregates in various
organs. Since we have shown that NEK1 +/- cells are
more sensitive to IR than cells from wild type litter-
mates [15], we know that haploid insufficiency for NEK1
also impairs DNA damage response and repair, even if it
does so to a lesser degree than complete inactivation of
NEK1 in null mice and cells. We hypothesized therefore
that NEK1 +/- kat2J mice should be prone to develop
cancers spontaneously. To examine this possibility, we
monitored tumor development in a cohort of NEK1 +/-
kat2J mice and wild type mice as they aged. By 17-24
months of age, 30% of wild type mice (3/10) and 89% of
NEK1 +/- kat2J littermate mice (33/36) developed lym-
phoid tumors. Tumors were discovered in many lym-
phatic chains, but most prominently in mesenteric
nodes. Some of the tumors invaded or metastasized to
parenchymal tissues such as lungs (Figure 6A). This
lymphoid tumor phenotype demonstrates, in vivo, that
haplo-insufficiency for NEK1 leads spontaneously to
cancer. We characterized the lymphoid tumors or
lymphomas in NEK1 +/- mice by immunohistochemical
analysis, using anti-CD3 antibodies for T-cells and anti-
CD45R antibodies for B-cells. The majority of the
tumors (17 of 32) failed to stain for either CD3 or
CD45R. Nine of 32 stained positively for CD45R
(B-cells), 2 were positive for CD3 (T cells), and 4 were
positive for both CD3 and CD45R (B- and T-cells)
(Figure 6A, B). Most cells in lymphoid tumors from
NEK1 +/- kat2J mice stained negatively for NEK1
(Figure 6A, panels e, f). This lack of staining suggests
that immunologically recognizable NEK1 may be lost in
somatic cells that acquire the transformed phenotype.
Analysis of a limited number of lymphoid tumors
from NEK1 +/- mice by FACS revealed that the cells
comprising them, and even some splenic lymphocytes
in older NEK1 +/- mice, have aberrant DNA content
(Figure 7 and additional file 1-Fig. S1). Cells from wild
type spleens and from spleens of young NEK1 +/- mice
without visible tumors served as controls. The cells
from the spleens of older mice had more than usual
complements of cells with 6n and 8n DNA content.
Cells from lymphoid tumors had not only polyploid
cells with 6n and 8n DNA, but many cells with non-
integer DNA content, characteristic of chromosome
pieces. In this regard, the lymphoid tumors from NEK1
+/- mice were similar to the NEK1 -/- cells in culture
(compare with Figure 3C).
Discussion
O u re a r l i e rs t u d i e sh a v es u ggested a role for NEK1 in
early DNA damage response and cell cycle checkpoint
activation [14,15]. The data presented here demonstrate
that cells deficient in NEK1 develop chromosomal
abnormalities during mitosis, and become aneuploid
after several division cycles. These abnormal cells gain
the ability to overcome density-dependent growth inhi-
bition, to grow in anchorage independent conditions,
and to form tumors in mice, i.e., they become malig-
nant. The studies in cultured cells were designed to
represent an accelerated version, telescoped in time, of
what happens to NEK1-deficient cells in vivo as they’re
exposed to oxidative stresses and other DNA-damaging
injuries. Interestingly, lymphoid tumor cells from older
NEK1 +/- mice had distinct, polyploid DNA contents
very similar to those seen in NEK1 -/- cells passed sev-
eral times in culture. Experiments using a complemen-
tary technique, FACS analysis in human U2OS tumor
cells with stable knock-down of NEK1 expression,
showed that NEK1 deficiency, not only the specific
NEK1/kat2J mutation, leads directly to acquisition of
the polyploid phenotype (additional file 2 Fig. S2B).
In kat2J mice with only one normal allele of NEK1,w e
observed an important consequence of defective DNA
damage repair and chromosome instability: a very high
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cumulative incidence of lymphomas in inbred C57Bl/6
mice is reported to be 30% [24]. We observed the same
incidence in our wild type mice, but a 3-fold greater
incidence in identically maintained NEK1 +/- litter-
mates. The lymphomas were heterogeneous, deriving
from B-, T-, and unclassifiable lymphocytes, suggesting
defects in repair of damaged DNA and in mitotic segre-
gation in multiple lineages and maturation steps, not in
any one particular lymphocyte differentiation pathway.
NEK1 null mice also developed lymphomas, but most of
them died at early ages from other causes. Lymphomas
or lymphoproferative disorders are common tumors in
mammals with DNA damage sensing or repair defects
[25-31]. Clones of lymphoid cells have to divide multiple
times, and they undergo frequent gene rearrangements
as they respond to different antigen epitopes throughout
the life of an animal. Many lymphocytes should also
undergo apoptosis as part of normal process of clonal
deletion. Lymphoid tumors therefore are especially
prone to acquire mutations, and to proliferate and
become malignant if they escape normal cell cycle
checkpoints, DNA damage repair mechanisms, or path-
ways to appropriate programmed death.
T h ed a t aw ep r e s e n th e r ea n di np r e v i o u sr e p o r t s
[14,15] concerning NEK1’s role in DNA damage and
mitotic checkpoint control is similar to what is known
about fungal NIMA. Aspergillus Nima mutants never
enter mitosis. Instead, they arrest in late G2 phase with
duplicated spindle pole bodies, the fungal equivalents of
mammalian cell centrosomes [32]. Overexpression of
NIMA in Aspergillus, yeast, and even in human cells,
Figure 6 Spontaneous lymphoid tumors in NEK1 +/- mice. NEK1 +/- and wild type mice were sacrificed at ages 17-24 months. Lymphoid
tumors were observed much more frequently in NEK1 +/- mice than in wild type littermates. A. Representative H&E stained sections of
lymphoid tumors, one from a mesenteric lymph node (panel a) and one within lung parenchyma (panel b). The same tumors were stained with
anti-CD3 to mark T-lymphocytes (panel c) and anti-CD45R to mark B-lymphocytes (panel d). Representative sections of lymphoid tumors stained
in with rabbit anti-NEK1 antibody: lymphoid tumor from a mesenteric node (panel e) and from a lung (panel f). Bar = 100 μM (panels a, b, e, f);
50 μM (panels c, d). B. Summary table of lymphoid tumors found in aged NEK1 +/- kat2J mice.
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pendent of CDC2, the proximal cyclin dependent kinase
controlling access to M phase [2,33-35]. If nimA5 Asper-
gillus mutants are forced to bypass G2/M phase check-
point arrest by acquisition of an additional mutation in
bimE7, an anaphase-promoting complex subunit APC1
[36], they develop grossly abnormal mitotic phenotypes:
multiple spindle pole bodies, spindles with disparate
sizes and shapes, disorganized microtubules arranged in
multiple directions other than orthogonal ones, and
defects in nuclear envelope structure and in nucleokin-
esis [4]. We observed similarly aberrant mitoses in mur-
ine NEK1 -/- cells after only a few division cycles in
culture. Our observations are intriguing, for in mammalian
cells NEK1 deficiency alone results in mitotic segregation
errors and aneuploidy, whereas bypassing the nimA5
mutation in Aspergillus requires an additional mutation in
bimE7 to get the cells past a mitotic checkpoint.
Our data suggests that NEK1 is not essential for entry
into mitosis, but instead that it is important for regulat-
ing the timing and fidelity of chromosome segregation
via its role in centrosomes and in generating bipolar,
orthogonal, mitotic spindles. Our studies highlight the
multifaceted nature of NEK1 function in DNA damage
checkpoint control and centrosomal function. Whether
the phenotypes observed in NEK1 -/- cells are due to
centrosome maintenance directly, to checkpoint activa-
tion, or both will require further investigation. NEK1
does localize to centrosomes, where it is thought to
affect the stability of primary cilia and centrosomes
directly, as well as cell cycle progression indirectly
through signaling and transcriptional programs [12,21].
Figure 7 Anueploidy in lymphoid tumors from older NEK1 +/- mice. Cells from the spleens of a 9 month-old wild type mouse and a NEK1
+/- mice littermate, 3 month-old NEK1 +/- mice, and three lymphoid tumors were fixed and stained with propidium iodide, and then analyzed
by FACS for DNA content. Percentages of 2n cells from the spleen from old NEK1 +/- mice and from a lymphoma were decreased compared to
cells from the spleens of wild type and young NEK1 +/- mice. Cells with DNA content greater than 4n were increased in the spleen cells from
old NEK1 +/- mice and in the lymphoid tumors. In the lymphoid tumor shown, note also the relatively large number of cells, characterized by
high valleys in the FACS plots, with non-integer DNA content. See also additional file 1-Fig. S1.
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domains have been shown using overexpressed, GFP-
tagged, deletion constructs to affect localization of
NEK1 to primary cilia and to g-tubulin in centrosomes
[12,21]. These experiments were performed in murine
renal inner medullary collecting duct (IMCD3) cells,
which express normal amounts of endogenous NEK1, so
they were not be able to address differential effects of
the various NEK1 deletion mutants on chromosomal
maintenance. To address this issue in light of our find-
ings of chromosome instability in NEK1-deficient cells,
identification and refinement of mutants that differen-
tially affect only NEK1 in centrosome function, in
checkpoint activation, or in the DNA damage repair
pathway will need to be made. These mutants would
then need to be added back to NEK1 -/- cells in order
to dissect the specific, differential functions of NEK1 in
chromosomal and checkpoint control phenotypes. We
have started such experiments.
Cells that divide without functional NEK1 develop
major defects in mitotic spindle function, thus com-
promising the cells’ ability to segregate chromosomes
faithfully to the two daughter cells, and resulting in
chromosome rearrangements and aneuploidy [37,38].
NEK1 -/- cells frequently have aberrant mitotic spindles
with lagging and misaligned chromosomes (Figure 2).
Such gross chromosomal rearrangements would result
in aneuploid cells that acquire copies of oncogenes or
lose tumor suppressors. Only a small subset of these
cells would gain a growth advantage and continue to
proliferate, whereas the majority of such cells, especially
those with too few chromosomes, would die by apopto-
sis. Polyploid cells gaining growth advantages eventually
would become the survivors, and they would proliferate
without proper regulation, as malignant cells do. Poly-
ploid NEK1 -/- cells are particularly remarkable in that
they do not always have integer multiples of n chromo-
somes. Instead, they often have pieces of chromosomes
and DNA content between 2n and 4n, or between 4n
and 6n (Figure 3), as well as micronuclei, multiple nuclei
of different sizes, or hollow nuclei in interphase cells
(Figure 1). These unique phenotypes suggest that NEK1
deficiency affects not only cytokinesis, but also affects
sister chromatid pairing and chromosomal rearrange-
ments like translocations, losses, and losses with
reduplications.
An argument can be made that the aneuploid pheno-
type observed in NEK1 -/- cells could be a secondary
effect, due to additional mutation in another locus.
Addressing this issue has been challenging, since re-
expression of wild type NEK1 in NEK1 -/- cells induces
checkpoint activation, such that those cells don’tc o n -
tinue to proliferate (additional file 2-Fig. S2A) and such
that mitotic cells are not observed. Differentiating direct
from secondary events might require in vivo experi-
ments, with transgenic mice overexpressing NEK1
crossed into the NEK1/kat2J -/- background, where the
mice could be observed for rescue of tumor formation
and genomic instability phenotypes.
A growing body of evidence from mouse models has
linked abnormal DNA damage repair and disturbed
mitotic events to the genesis and progression of cancer
(for review see [39]). NEK1 does not appear to be abso-
lutely required for development in mice, which seem
not to acquire prominent aneuploid phenotypes during
embryonic stages. Excessive a p o p t o s i si se v i d e n ti nt h e
kidneys and other organs of embryonic and newborn
NEK1/kat2J -/- mice, however (manuscript in prepara-
tion). This observation suggests that cells with abnormal
chromosomes content are eliminated during develop-
ment. NEK1’s role in DNA damage responses may be
subtle and regulatory, akin to the role associated with
the key DNA damage response kinase ataxia telangiecta-
sia mutated (ATM) [40]. Nek1-null mice seem to be in
important ways similar to Atm-deficient mice and
humans with ataxia-telangiectasia, which survive
embryonic and early adult stages, but which age prema-
turely and develop lymphomas and other tumors later
in life as they’re exposed to environmental insults [26].
The ATM and Rad3-related kinase (ATR), in contrast to
ATM and NEK1, is more fundamental in signaling path-
ways required for recognition and repair of DNA repli-
cation intermediates, and results in early embryonic
lethality with fragmented chromosomes when mutated
[41]. We suggest that repeated injuries over time may
need to accumulate in order to manifest gross chromo-
somal abnormalities and cancers late in the life of
a NEK1-deficient animal, as in the life of an ATM-
deficient animal. Such injuries would not occur much
during embryonic development.
Our current results showing that mice heterozygous
for NEK1 have a high cumulative incidence of lympho-
mas, derived from all types of lymphocytes, suggests
that low level expression of NEK1 in cells expressing it
f r o mas i n g l ea l l e l ei sn o ts u f f i c i e n tt os a f e g u a r dt h e
genome and prevent chromosome instability. Since
NEK1 is important for DNA damage response/repair
and centrosome maintenance, the expression of suffi-
cient amounts of NEK1 might be required for proper
mitotic checkpoint activation and for assuring precise
mitotic chromosomal segregation and cellular cytokin-
esis. Studying the level of NEK1 expression in different
human cancers will help to determine whether chromo-
some instability observed in these cancers can be attrib-
uted to loss of NEK1 activity, and whether NEK1 could
be an important target for cancer treatment. We know
of no published studies to date that have implicated
NEK1 mutations in the pathogenesis of human tumors.
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leads to tumor formation in humans should be explored.
Conclusions
NEK1 is required for maintaining chromosome stability.
Cells without functional NEK1 generate abnormal mito-
tic spindles with lagging chromosomes, become aneu-
ploid, overcome density-dependent growth inhibition,
proliferate without anchorage dependence, and gain the
ability to form tumors when injected into syngeneic
mice. NEK1 deficiency and the chromosome instability
associated with it also have consequences in vivo: NEK1
heterozygous mice develop lymphomas with a much
higher incidence than wild type littermates. These
observations, when combined with our previous reports
about the role of NEK1 in DNA damage checkpoint
control, suggest that NEK1 is important for safeguarding
the genome, by participating in the DNA damage and
responses, and by assuring faithful chromosome segrega-
tion during mitosis.
Additional material
Additional file 1: Figure S1: Anueploidy in lymphoid tumors from
older NEK1 +/- mice. FASC analysis results of spleens and lymphoid
tumor. Raw height and FL2 area plots of cells from representative
spleens and a lymphoid tumor. Note the scatter in the lymphoid tumor
cells, representing cells with non-integer DNA content.
Additional file 2: Figure S2: Cell cycle arrest of NEK1 -/- cells after
retroviral-mediated expression of wild type NEK1 and aneuploidy in
NEK1 knocked down cells. Re-expression of NEK1 into NEK1-/- cells
induced cell cycle arrest and silencing NEK1 expression in U2-OS cells
increases polyploidy in higher passage cells.A. FACS analysis of NEK1 -/-
cells after retroviral-mediated expression of wild type NEK1. Nek1/kat2J
-/- cells were infected with a retrovirus expression vector for NEK1 under
control of a UBC promoter. The expression of NEK1 was detected by
Western blotting. Expression of p84 served as a control for loading. Five
days after infection, cells were fixed, immunostained with anti-phospho-
H3 antibodies, and anaylyzed by FACS. B. U2-OS cells with NEK1
expression knocked down by stable RNA silencing. U2-OS cells were
transfected with a NEK1 shRNAi construct. Stable NEK1 knockdown cells,
N27, were selected and propagated. At passages 5 and 7, the cells were
fixed and analyzed by FACS. Increasing polyploidy was evident in the
higher passage N27 cells.
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